XML 63 R47.htm IDEA: XBRL DOCUMENT
v3.20.4

Goodwill and in Process Research and Development (Brooklyn ImmunoTherapeutics, LLC) (10-K) | 12 Months Ended
--- | ---
Dec. 31, 2019
Brooklyn Immunotherapeutics, LLC [Member] |
Goodwill and In Process Research and Development | NOTE 6 GOODWILL AND IN PROCESS RESEARCH AND DEVELOPMENT The Company recorded Goodwill and IPR&D in the amount of $2,043,747 and $6,860,000, respectively, in connection with the Business Combination (see Note 4 – Business Combination). IPR&D assets are considered to be indefinite-lived until the completion or abandonment of the associated research and development projects.

X
- Definition Goodwill and in process research and development [Text Block]. + References No definition available. + Details
Name: | NTN_GoodwillAndInProcessResearchAndDevelopmentTextBlock
Namespace Prefix: | NTN_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=NTN_BrooklynImmunotherpeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |